Form D · Biotechnology
Trellis Bioscience, Inc.
Redwood City, CA · CIK 0001162015
Offering snapshot reported Oct 21, 2026 · SEC filing
- Reported sold
- $22.9M Indefinite offering
- Investors reported
- 88 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 29, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 21, 2026 | Initial | $22,892,056 | No comparison | 88 | SEC filing |
| Oct 21, 2026 | Initial | $985,000 | No comparison | 6 | SEC filing |
| Oct 21, 2026 | Initial | $1,350,000 | No comparison | 9 | SEC filing |
| Oct 21, 2026 | Initial | $4,094,500 | No comparison | 27 | SEC filing |
| May 15, 2026 | Initial | $6,093,000 | No comparison | 16 | SEC filing |
| Nov 9, 2011 | Initial | $235,000 | No comparison | 8 | SEC filing |
| Aug 7, 2009 | Amendment | $11,715,708 | $265,513vs Jul 17, 2009 | 12 | SEC filing |
| Jul 17, 2009 | Initial | $11,450,195 | No comparison | 5 | SEC filing |
| Feb 11, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Dec 7, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 10, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 7, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 24, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Other
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-602063
Series B Interests
Source: Form D, filed Oct 21, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Broderick | Director |
| Geoff Dillon | Executive |
| Stote Ellsworth | Director, Executive |
| John Friedman | Director |
| Markus Goebel | Director |
| Lawrence Kauvar | Director, Executive |
| Larry Kauvar | Executive |
| Thomas Lavin | Director |
| Gerald Mc Mahon | Director |
| Nora Mende | Executive |
| Stefan Ryser | Executive |
| Somu Subramaniam | Director |
| Elisabeth Whitney | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
702 Marshall Street Suite 301
Redwood City, CA, 94063
Phone: 408-772-8049
Redwood City, CA, 94063
Phone: 408-772-8049